Trial Profile
Extended-release quetiapine versus immediate-release quetiapine in older Alzheimer's disease patients with symptoms of agitation and/or psychosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2012
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Agitation; Alzheimer's disease; Psychotic disorders
- Focus Adverse reactions
- 01 Mar 2012 Results published in the International Journal of Geriatric Psychiatry.
- 14 Feb 2012 New trial record